Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-11-045856
Filing Date
2011-08-10
Accepted
2011-08-10 20:28:28
Documents
1
Period of Report
2011-08-08

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 8403
  Complete submission text file 0001104659-11-045856.txt   9559
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAXTON ASSOCIATES 500 PARK AVENUE NEW YORK NY 10022
Business Address
Kovner Bruce (Reporting) CIK: 0001325713 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 111025727